Afya Ltd

Chart & Performance

D1W1MN

No data to show

P/E

14.73

P/S

2.81

EPS

6.99

Div Yield, %

—

Shrs. gr., 5y

3.65%

Rev. gr., 5y

34.50%

Revenues

3.30b

+14.90%

Net income

632m

+63.47%

CFO

1.43b

+37.28%

Earnings

Jun 05, 2025

Profile

Afya Limited, through its subsidiaries, operates as a medical education group in Brazil. It offers educational products and services, including medical schools, medical residency preparatory courses, graduate courses, and other programs to lifelong medical learners enrolled across its distribution network, as well as to third-party medical schools. The company also provides digital health services, such as subscription-based mobile app and website portal that focuses on assisting health professionals and students with clinical decision-making through tools, such as medical calculators, charts, and updated content, as well as prescriptions, clinical scores, medical procedures and laboratory exams, and others. It offers health sciences courses, which comprise medicine, dentistry, nursing, radiology, psychology, pharmacy, physical education, physiotherapy, nutrition, and biomedicine; and degree programs and courses in other subjects and disciplines, including undergraduate and post graduate courses in business administration, accounting, law, civil engineering, industrial engineering, and pedagogy. In addition, the company provides medical postgraduate specialization programs; printed and digital content; and an online medical education platform and practical medical training services. As of December 31, 2021, it operated a network of 46 undergraduate and graduate medical school campuses consisted of 30 undergrad operating units and five approved units; and a network of 2,731 medical school seats that consisted of 2,481 operating seats and 278 approved seats. The company was founded in 1999 and is headquartered in Nova Lima, Brazil.

URL

https://www.afya.com.br/

IPO date

Jul 19, 2019

Employees

5,260

Domiciled in

Incorporated in

Valuation

Order:

Title BRL in thousands, except ratios and share amounts	FY	FY	FY	FY	FY	FY	FY	FY
Title BRL in thousands, except ratios and share amounts	2024‑12	2023‑12	2022‑12	2021‑12	2020‑12	2019‑12	2018‑12	2017‑12
Income
Revenues	3,304,329 14.90%	2,875,913 23.48%	2,329,057 35.46%
Cost of revenue	1,235,689	2,146,001	1,667,141
Unusual Expense (Income)
NOPBT	2,068,640	729,912	661,916
NOPBT Margin	62.60%	25.38%	28.42%
Operating Taxes	27,471	24,166	35,677
Tax Rate	1.33%	3.31%	5.39%
NOPAT	2,041,169	705,746	626,239
Net income	631,510 63.47%	386,324 3.41%	373,569 67.28%
Dividends
Dividend yield
Proceeds from repurchase of equity		(12,369)	(152,317)
BB yield		0.62%	10.84%
Debt
Debt current	409,134	216,150	239,837
Long-term debt	3,742,699	3,333,763	3,244,290
Deferred revenue
Other long-term liabilities	614,398	423,708	568,927
Net debt	3,186,376	2,945,049	2,337,138
Cash flow
Cash from operating activities	1,432,659	1,043,623	843,899
CAPEX	(136,924)	(118,435)	(297,024)
Cash from investing activities	(1,091,613)	(1,143,051)	(591,469)
Cash from financing activities	23,966	(439,943)	92,942
FCF	1,916,762	561,612	477,573
Balance
Cash	911,015	553,030	1,093,082
Long term investments	54,442	51,834	53,907
Excess cash	800,241	461,068	1,030,536
Stockholders' equity	2,240,017	1,421,889	1,179,761
Invested Capital	7,298,237	6,280,996	5,460,779
ROIC	30.06%	12.02%	11.86%
ROCE	25.54%	10.83%	10.20%
EV
Common stock shares outstanding	91,155	90,537	89,937
Price	15.88 -27.59%	21.93 40.40%	15.62 -0.57%
Market cap	1,447,536 -27.09%	1,985,473 41.33%	1,404,809 -4.98%
EV	4,674,540	4,972,029	3,793,267
EBITDA	2,401,981	1,019,423	868,136
EV/EBITDA	1.95	4.88	4.37
Interest		386,296	288,652
Interest/NOPBT		52.92%	43.61%